Study #2021-0049
HSP70 as a target for New drugs in Multiple Myeloma and Lymphoma
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Targeting HSP70 in Myeloma and Lymphoma
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Robert Orlowski
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-833-753-1037
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.